Berkshire生物医学在即将举行的网络研讨会上揭幕了COPATM,这是一个生物鉴别药物交付系统。 Berkshire Biomedical unveils COPA™, a biometric medication delivery system, in an upcoming webinar.

Berkshire生物医学将于2025年4月8日主办一次网络研讨会,展示其COPATM技术,这是一个药物提供系统,使用指纹和识别生物鉴别技术,以确保只有预定用户才能获得药物。 Berkshire Biomedical will host a webinar on April 8, 2025, to showcase its COPA™ technology, a medication delivery system that uses fingerprint and dentition biometrics to ensure only the intended user can access medication. 该系统旨在提高疼痛管理和阿片类药物使用紊乱治疗的安全和合规性。 The system aims to improve safety and adherence in pain management and opioid use disorder treatment. 这次活动与公司在StartEngine上众筹股权的最后阶段相吻合,并将提供现场演示和与领导层的问答. The event coincides with the company's final phase of equity crowdfunding on StartEngine and will feature a live demo and Q&A with leadership.